Klag Thomas, Wehkamp Jan
Dtsch Med Wochenschr. 2018 Jul;113(13):953-959. doi: 10.1055/a-0538-3671. Epub 2018 Jul 4.
New promising treatment options for chronic inflammatory bowel diseases, confirm the expanded pathophysiological understanding in terms of the interactions of the gastrointestinal microbiome with the adaptive and innate immune response and barrier protection. Therefore, these interrelations are focus of research and therapeutic strategies. The following review will give insights into the pathomechanisms, current treatment options and future developments.
针对慢性炎症性肠病的新的有前景的治疗选择，证实了在胃肠道微生物群与适应性和先天性免疫反应及屏障保护的相互作用方面，我们对病理生理学有了更广泛的认识。因此，这些相互关系是研究和治疗策略的重点。以下综述将深入探讨发病机制、当前的治疗选择及未来的发展。
